LEADER 01473nam2-2200433---450 
001 990006001360203316
005 20170315132644.0
010   $a978-0-470-77005-4
035   $a000600136
035   $aUSA01000600136
035   $a(ALEPH)000600136USA01
035   $a000600136
100   $a20030911d2010----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $aaf--z|||001yy
200 1 $a<<v. 4:>> Cardiovascular, endocrine and metabolic diseases$fedited by Donald J. Abraham, David P. Rotella
205   $a7. ed.
210   $aHoboken [etc.]$cJ. Wiley & Sons$dcopyr. 2010
215   $aIX, 685 p.$cill.$d26 cm
461  1$1001000600086$12001$aBurger's medicinal chemistry,drug discovery and development
606 1 $aChimica farmaceutica
676   $a615.19
702  1$aABRAHAM,$bDonald J.
702  1$aROTELLA,$bDavid P.
801  0$aIT$bSalbc$cISBD
856  4$uhttp://mrw.interscience.wiley.com/emrw/9780471266945/home/$4.$zaccessibile on-line
912   $a990006001360203316
951   $a615.19 BUR 4 4$b5769/D Farm.$c615$d00330476
951   $a615.19 BUR 4 4a$b2843/D Med.$c615$d00335987
959   $aBK
969   $aMED
969   $aFAR
979   $aPAOLA$b90$c20150128$lUSA01$h1320
979   $aPAOLA$b90$c20150128$lUSA01$h1320
979   $aPAOLA$b90$c20150128$lUSA01$h1323
979   $aPAOLA$b90$c20150128$lUSA01$h1519
996   $aCardiovascular, endocrine and metabolic diseases$91078923
997   $aUNISA